The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows
- PMID: 19620039
- DOI: 10.1684/ejd.2009.0766
The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows
Abstract
Latanoprost is an analogue of prostaglandin F(2alpha) which is used to treat glaucoma. Increases in eyelash number, thickness, and pigmentation have been reported as latanoprost side effects. The aim of this study was to evaluate if topical use of this drug can be used as a treatment of alopecia areata of eyebrows and eyelashes or not. In an experimental study, 26 patients with symmetrical eyelash and eyebrow alopecia areata were treated over 4 months with topical latanoprost for one side and the other side was not treated with any drug. The results were compared. Only one of the latanoprost-treated cases showed partial hair regrowth on the treated side. The relationship between hair regrowth and latanoprost application was not statistically significant (P = 1) by Fisher test. Based on our results, topical latanoprost has no efficacy in the treatment of alopecia areata. More studies with a larger sample size, longer study duration, and higher concentration of medication are suggested.
Similar articles
-
Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis.J Eur Acad Dermatol Venereol. 2010 Apr;24(4):481-5. doi: 10.1111/j.1468-3083.2009.03543.x. Epub 2009 Dec 17. J Eur Acad Dermatol Venereol. 2010. PMID: 20028444 Clinical Trial.
-
Cutaneous latanoprost in the treatment of alopecia areata.Eye (Lond). 2003 Apr;17(3):444-6. doi: 10.1038/sj.eye.6700354. Eye (Lond). 2003. PMID: 12724722 No abstract available.
-
Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.J Am Acad Dermatol. 2009 Apr;60(4):705-6. doi: 10.1016/j.jaad.2008.08.029. J Am Acad Dermatol. 2009. PMID: 19293023 Clinical Trial. No abstract available.
-
Congenital alopecia areata.J Am Acad Dermatol. 2005 Feb;52(2 Suppl 1):8-11. doi: 10.1016/j.jaad.2004.06.024. J Am Acad Dermatol. 2005. PMID: 15692503 Review.
-
Treatment for facial alopecia areata: A systematic review with evidence-based analysis.J Am Acad Dermatol. 2018 Mar;78(3):601-605. doi: 10.1016/j.jaad.2017.09.054. Epub 2017 Oct 4. J Am Acad Dermatol. 2018. PMID: 28987491 No abstract available.
Cited by
-
Eyebrow and Eyelash Alopecia: A Clinical Review.Am J Clin Dermatol. 2023 Jan;24(1):55-67. doi: 10.1007/s40257-022-00729-5. Epub 2022 Oct 2. Am J Clin Dermatol. 2023. PMID: 36183302 Free PMC article. Review.
-
Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs.Clin Cosmet Investig Dermatol. 2023 Mar 31;16:803-820. doi: 10.2147/CCID.S376096. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 37025396 Free PMC article. Review.
-
Female pattern alopecia: current perspectives.Int J Womens Health. 2013 Aug 29;5:541-56. doi: 10.2147/IJWH.S49337. Int J Womens Health. 2013. PMID: 24039457 Free PMC article. Review.
-
Alopecia areata: Part 2: treatment.Can Fam Physician. 2015 Sep;61(9):757-61. Can Fam Physician. 2015. PMID: 26371098 Free PMC article. Review.
-
Ruxolitinib found to cause eyelash growth: a case report.J Med Case Rep. 2017 Jul 12;11(1):189. doi: 10.1186/s13256-017-1304-5. J Med Case Rep. 2017. PMID: 28701183 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical